Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schreiber Alain
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   12,051,047    

Indirect Shares

   11,491,339      
Direct Value   $27,048,039    

Indirect Value

   $2,572,716      
Total Shares   23,542,386      
Total Value   $29,620,756      


Molecular Templates, Inc. $81,877 Palatin Technologies Inc $10,447,150 Cadence Pharmaceuticals Inc $0 Optimer Pharmaceuticals Inc $0 Immune Design Corp. $0 Urogen Pharma Ltd. $16,519,012 Molecular Templates, Inc. $81,877 Palatin Technologies Inc $10,447,150 Cadence Pharmaceuticals Inc $0 Optimer Pharmaceuticals Inc $0 Immune Design Corp. $0 Urogen Pharma Ltd. $16,519,012
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Molecular Templates, Inc. MTEM 10% Owner 2005-10-28 136,417 2005-10-28 3,385,203    Premium*  
            Palatin Technologies Inc PTN 10% Owner 2005-11-29 5,803,972 2005-11-29 0    Premium*  
            Cadence Pharmaceuticals Inc CADX Director, 10% Owner 2007-09-19 2,882,269 2006-10-30 12,500    Premium*  
            Optimer Pharmaceuticals Inc OPTR Director 2008-07-18 2,500 2009-03-04 811,998    Premium*  
            Avanir Pharmaceuticals AVNR 10% Owner 2008-08-06 0 2009-10-13 7,125,754    Premium*  
            Eagle Pharmaceuticals, Inc. EGRX 10% Owner 0 2017-05-15 155,884    Premium*  
            Immune Design Corp. IMDZ 10% Owner 2015-05-12 1,983,858 2015-03-05 0    Premium*  
            Urogen Pharma Ltd. URGN 10% Owner 2017-11-28 1,242,031 0    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
MTEM Molecular Templates, Inc. 10% Owner   –       –       •   2005-02-04 3 IO $0.00 $0 D/D 0 3,440,205 -
MTEM Molecular Templates, Inc. 10% Owner   –       –       •   2005-10-28 4 S $10.46 $577,204 D/D (55,182) 136,417 -
MTEM Molecular Templates, Inc. 10% Owner   –       –       •   2005-10-28 4 S $10.46 $577,204 I/I (55,182) 3,385,203 -
PTN Palatin Technologies Inc officerTitle   –       –       •   2005-11-29 4 S $3.90 $1,402,318 D/D (358,000) 5,803,972 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2006-10-30 4 A $0.00 $0 D/D 3,053,174 3,053,174 0 -
OPTR Optimer Pharmaceuticals I... Director   –       •      –    2007-02-14 4/A OE $7.00 $1,050,000 I/I 150,000 54,106 0 -
OPTR Optimer Pharmaceuticals I... Director   –       •      –    2007-02-14 4 OE $1.08 $110,766 I/I 102,561 48,001 0 -
OPTR Optimer Pharmaceuticals I... Director   –       •      –    2007-02-14 4 A $0.00 $0 I/I 1,076,902 43,827 0 -
OPTR Optimer Pharmaceuticals I... Director   –       •      –    2007-09-12 4 A $0.00 $0 I/I 2,500 2,500 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2007-09-12 4 S $13.50 $33,940 D/D (2,500) 2,919,669 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2007-09-14 4 S $13.50 $6,750 D/D (500) 2,919,169 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2007-09-17 4 S $13.50 $2,700 D/D (200) 2,918,969 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2007-09-18 4 S $13.50 $106,650 D/D (7,900) 2,911,069 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2007-09-19 4 S $14.10 $409,919 D/D (28,800) 2,882,269 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2007-09-19 4 S $13.50 $1,032,727 D/D (74,300) 2,807,969 0 -
OPTR Optimer Pharmaceuticals I... Director   –       •      –    2008-07-18 4 B $8.48 $7,999,998 I/I 943,396 628,931 2.1 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-05 3 IO $0.00 $0 I/I 0 7,820,470 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-06 4 B $0.90 $360 I/I 400 7,820,870 1.42 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-07 4 B $0.98 $89,552 I/I 91,380 7,912,250 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-14 4 B $0.90 $5,446 I/I 6,051 7,918,301 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-15 4 B $0.95 $108,330 I/I 114,032 8,032,333 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-27 4 B $0.95 $84,975 I/I 89,447 8,121,780 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-09-02 4 B $0.93 $300,902 I/I 323,550 8,445,330 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-09-03 4 B $0.93 $6,384 I/I 6,864 8,452,194 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-09-04 4 B $0.95 $49,507 I/I 52,113 8,504,307 1.5 -
  117  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us